MD Anderson and Jazz Pharmaceuticals collaborate to evaluate treatment options for hematol
The University of Texas MD Anderson Cancer Center and Jazz Pharmaceuticals plc today announced a five-year collaboration agreement with a goal of evaluating therapies for...








